Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b trial of topical tofacitinib ointment in chronic plaque psoriasis
2012-005645-20Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tofacitinib in psoriasis and plaque psoriasis (6 arms), sponsored by Pfizer. Primary endpoints: PGA-C response at Week 8 and PGA-C response at Week 12. Started Jun 2013; status: completed.
02
Drugs
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on 2012-005645-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005645-20.